Sildenafil for women patients with antidepressant-induced sexual dysfunction

8 : Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder.

Start searching for free in Consensus!

Because it can interact with other medications, a doctor must confirm if the arousal cream is safe for you to use based on your health history. Sildenafil Arousal Cream is a localized treatment, and side effects are uncommon. However, some women may experience mild irritation in the vaginal area. If this occurs, consult with your Winona physician, who can identify if there’s a need to discontinue the medication. If you apply Sildenafil Arousal Cream at least 30 minutes prior to sexual activity, it should not affect your partner.

Increased genital blood flow

Just remember to properly clean all devices to remove any product residue or bodily fluids. No, do not use Sildenafil Arousal Cream if you are also taking a nitrate drug for chest pain or heart problems, including nitroglycerin, isosorbide dinitrate, isosorbide mononitrate, or some recreational drugs like “poppers” (alkyl nitrites). Using a product that contains sildenafil together with a nitrate medication can cause a sudden and serious decrease in blood pressure. No, Sildenafil Arousal Cream should not be used by pregnant women or those attempting to become pregnant. No, it’s not necessary to remove pubic hair before application.

Sexual dysfunction in the United States: prevalence and predictors

However, for some women, removing hair in the area can facilitate easier application and help with cream absorption. Sildenafil Arousal Cream should be stored at room temperature, away from moisture and heat. Keep the container securely closed when not in use. You can get your prescription by completing our online onboarding process. This starts with a free intake where you'll answer questions about your health and symptoms. 9 : Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i). 10 : Androgen-dependent nitric oxide release in rat penis correlates with levels of constitutive nitric oxide synthase isoenzymes.

11 Guay, A., Munarriz, R., Jacobson, M.A., Talakoub, L., Goldstein, I., Traish, A. et-al: Androgen values in premenopausal women without sexual dysfunction. Presented at International Society for the Study of Women's Sexual Health, Vancouver, British Columbia, Canada, October 10–13, 2002 Google Scholar 13 : Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med2002; 11: 277. 14 : The use of the Female Intervention Efficacy Index (FIEI) as an immediate outcome measure of medical intervention to treat female sexual dysfunction. 15 : Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med2002; 11: 367.

Access through your organization

All patients had protocol specified estradiol and free testosterone concentrations or were receiving estrogen and/or androgen replacement therapy. 1 : Report of the International Consensus Development Conference on Female Sexual Dysfunction: definitions and classifications. 2 : Female sexual arousal disorder: new insights. 5 : Development of human and rabbit vaginal smooth muscle cell cultures: effects of vasoactive agents on intracellular levels of cyclic nucleotides. 7 : Sildenafil, a novel effective oral therapy for male erectile dysfunction. 16 : Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. 17 : Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. 18 : Effects of ovariectomy and estrogen and androgen treatment on sildenafil-mediated changes in female genital blood flow and vaginal lubrication in the animal model. 19 : The role of androgen in the maintenance of sexual functioning in oophorectomized women.

• Future studies may clarify sildenafil’s effectiveness for women.
• Regulatory approval for women may be granted if proven safe.
• Personalized medicine approaches could enhance treatment outcomes.
• In the meantime, women should seek professional advice before use.

20 : Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality.

• Sildenafil’s interaction with other medications is an important consideration.
• It has a different impact depending on individual health conditions.
• Data on long-term effects of sildenafil in women are inconclusive.
• Use only under medical supervision to minimize risks.

From the Department of Urology, University of California-Los Angeles Medical Center, Los Angeles, California, Departments of Obstetrics and Gynecology, and Psychiatry, Feinberg School of Medicine, Northwestern Memorial Hospital, Chicago, Illinois, and Pfizer Global Research and Development, Groton, Connecticut, and Sandwich, United Kingdom Topical sildenafil cream is effective for improving outcomes in women with female sexual arousal disorder, according to a recent study published in Obstetrics & Gynecology.1 Topical sildenafil cream has shown promising results in improving sexual arousal outcomes for women with female sexual arousal disorder.

Treatment Information

A board-certified doctor will then review your information to determine if you are a candidate for treatment and, if so, will issue a prescription for Sildenafil Arousal Cream. Once your prescription is issued, there’s a 24-hour review period before the pharmacy begins processing your order. The pharmacy typically prepares your medication within 1–3 business days, followed by shipping, which takes another 1–3 business days. On average, most patients receive their Sildenafil Arousal Cream within about 5 business days. Your Sildenafil Arousal Cream is delivered directly to your door.

A note about sex and gender

Standard shipping is free on all prescriptions. If you need your medication sooner, expedited options are available at checkout, including USPS Priority (2–3 business days) or FedEx Overnight for an additional fee. While Winona is currently unable to bill insurance companies directly, you can use your HSA (Health Savings Account) or FSA (Flexible Spending Account) card to pay for your Sildenafil Arousal Cream at checkout. You’ll also have access to receipts and documentation that you can use to submit and file a claim with your insurance provider for possible reimbursement. The active ingredients in your Sildenafil Arousal Cream, sildenafil and pentoxifylline, are FDA approved.

Comparison table

The final medication itself is prepared for you by a state-licensed compounding pharmacy that follows strict quality standards. Winona’s Sildenafil Arousal Cream is only available in one standard dose. Your Winona prescription includes unlimited, 24/7 messaging with your board-certified doctor. You can ask questions about your Sildenafil Arousal Cream, discuss your symptoms, or explore Winona’s other treatments at any time through the secure Patient Portal. When you need more Sildenafil Arousal Cream, simply request a reorder through your Patient Portal, and the Patient Care Team will arrange shipment. The study, published in Obstetrics & Gynecology, found that women using sildenafil cream experienced significant improvements in sexual arousal sensation compared to those using a placebo.

• Sildenafil may improve blood flow, but effectiveness varies.
• The drug is not FDA-approved specifically for female use.
• Ongoing research aims to determine its safety for women.
• Lifestyle changes and therapy are often preferred first-line treatments.

Phase 1 and phase 2 studies indicated that sildenafil cream is safe, well-tolerated, and effective for treating female sexual arousal disorder. Significant improvements were observed in the SFQ28 Desire domain scores at week 8, especially in women with only female sexual desire disorder. Researchers suggest future studies should include a more diverse population by removing restrictions on enrolling sexual partners, to better evaluate the cream's efficacy.

Female sexual arousal disorder, presenting in approximately 20% of US women, refers to the inability to attain or maintain sexual arousal and often leads to distress and interpersonal difficulty.

Currently, no pharmacologic treatments have received FDA approval for managing this condition in the United States.

• Some studies investigate sildenafil’s impact on vaginal blood flow.
• Psychological factors also significantly influence female sexual response.
• Not all women will experience improved sexual function with sildenafil.
• Sexual therapy remains an important treatment option.

While oral sildenafil has shown little efficacy compared to placebo and high rates of side effects, topical sildenafil cream 3.6% (sildenafil cream) is another method of managing female sexual arousal disorder symptoms.

Sildenafil Arousal Cream FAQs

We evaluated the efficacy and safety of sildenafil citrate in spontaneously or surgically postmenopausal women with female sexual arousal disorder (FSAD). Sildenafil (a 50 mg dose adjustable to 100 or 25 mg) was evaluated in a 12-week, double-blind, placebo controlled study in 202 postmenopausal women with FSAD who had protocol specified estradiol and free testosterone concentrations, and/or were receiving estrogen and/or androgen replacement therapy. Patients were excluded if emotional, relationship or historical abuse issues contributed significantly to sexual dysfunction. Primary end points were questions 2 (increased genital sensation during intercourse or stimulation) and 4 (increased satisfaction with intercourse and/or foreplay) from the Female Intervention Efficacy Index (FIEI). Secondary end points were sildenafil 100mg blue pill the remaining questions from this index, the Sexual Function Questionnaire and sexual activity event log questions.

Osphenia (Ospemifene)

Significant improvements in FIEI questions 2 (p = 0.017) and 4 (p = 0.015) were noted with sildenafil compared with placebo. For women with FSAD without concomitant hypoactive sexual desire disorder (HSDD) sildenafil was associated with significantly greater improvement in 5 of 6 FIEI items compared with placebo (p <0.02). No significant improvements were shown for women with concomitant HSDD. Most adverse events were mild to moderate with headache, flushing, rhinitis, nausea and visual symptoms reported most frequently. Sildenafil was effective and well tolerated in postmenopausal women with FSAD without concomitant HSDD or contributory emotional, relationship or historical abuse issues. Topical administration of sildenafil may also reduce side effects and provide a more immediate biological efficacy response. Sildenafil cream is an investigational proprietary topical formulation designed for the treatment of female sexual arousal disorder.2 Phase 1 and phase 2 studies have indicated safety, tolerance, and efficacy from sildenafil cream use. Investigators conducted a clinical trial to evaluate the safety and efficacy of sildenafil cream among women with female sexual arousal disorder.1 Participants included healthy premenopausal women aged at least 18 years and their sexual partners. Female sexual arousal disorder outcomes were assessed using the Arousal Sensation domain of the Sexual Function Questionnaire (SFQ38) and question 14 of the Female Sexual Distress Scale—Desire, Arousal, Orgasm (FSDS-DAO).